Peculiarities of course and treatment of thyroid diseases in women peri-and postmenopausal period


Citar

Texto integral

Resumo

The problem of thyroid gland (TG) in women in peri- and postmenopausal period is discussed. There is a similarity between the symptoms of climacteric syndrome and symptoms of thyroid dysfunction in women in perimenopausal period that creates objective prerequisites for hyperdiagnostics of thyroid diseases. On the other side, the clinical manifestations of thyroid disease in older women often have atypical characteristic and more likely subclinical variants of the disease course compared with younger women. Prevalence of thyroid disease in women older than 50 years, and the lack of specific symptoms in most patients making more difficult diagnosis, confirm the need for timely screening and specialized examinations of menopausal women by endocrinologist.

Sobre autores

T Berketova

T Berketova

Bibliografia

  1. Беркетова Т.Ю. Течение менопаузы и особенности проведения заместительной гормональной терапии у женщин с гипотиреозом, тиреотоксикозом и гиперпролактинемическим гонадизмом. Автореф. дисс. канд. мед. наук. 1999.
  2. Герасимов Г.А., Александрова Г.Ф., Внотченко С.Л. Болезни щитовидной железы. В кн.: Алгоритмы диагностики и лечения болезней эндокринной системы. 1995. С. 80-96.
  3. Мельниченко Г.А., Петрова Н.Д. Современные подходы к лечению синдрома тиреотоксикоза // Клиническая фармакология и терапия. 1997. № 1. С. 60-65.
  4. Arem R, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy. Arch Intern Med 1990;150:2097-100.
  5. Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years. Arch Intern Med 1990;145:785-87.
  6. Bahemuka M, Hodkinson NM. Screening for hypothyroidism in elderly patients. Br Med J 1975;2:601-03.
  7. Baran DT, Braverman LE. Thyroid hormone and bone mass. J Clin Endocrinol Metab 1991;72:1182-83.
  8. Bartalena L, Brogioni S, Grasso L, et al. 1994 Serum interleukin-6 concentration to changes to changes of thyroid function in nonthyroidal illness. J Endocrinol Invest 4. Bartalena L, Grasso L, Brogioni S et al. Serum interleukin-6 in amiodaron thyrotoxicosis. J Clin Endocrinol Metab 1994;78:423-27.
  9. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Endocrinol Metab Clin North Am 1993;22:263-77.
  10. Campbell AJ, Reinken J, Allan BC. Thyroid disease in the elderly in the community. Age Ageing 1981;10:47-52.
  11. Campos-Pastor MM, Munos-Torres M, Escobar-Jimenes F, et al. Bone mass in females with different thyroid disorders: influence of menopausal status. Bone Mineral 1993;21:1.
  12. Caron P, Calazel C, et al. Decreased cholesterol HDL in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol 1990;33:519-23.
  13. Cavalierei, RR (Nucl. Med. Serv., Univ. of California, San Fr., California) The effects of nonthyroidal disease and drugs on thyroid function tests. Med Clin North Am 1991;75:27-39.
  14. Chiovato Luca, Ferrucio Santini, Aldo Pinchera. Лечение гипертиреоза. 1997. С. 27-38.
  15. Delange F. Iodine deficiency in Europe. Thyroid International 1994;3:20.
  16. Diamnd T, Nery L, Hales Y. A therapeutic dilemma: supressive doses of thyroxine reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 1990;72:1184-88.
  17. Dillmann WH. Thyroid hormones and the heart: Basic mechanistic and clinical issues. Thyroid Today 1996;19:1-11.
  18. Felicetta JV. Thyroid disease in the elderly. Special features changes in management. Postgrad Med 1998;83:145-60.
  19. Fenzi GF, Ceccarelli C, Macchia E, et al. Reciprocal changes of serum thyroglobulin and TSH in residents of a moderate endemic goiter area. Clin Endocrinol (Oxf) 1985;23:115-22.
  20. Fradkin JE, Wolff J. Iodine-induced thyrotoxicosis. Medicine 1983;62:1-20.
  21. Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994;330:1731-38 (1-339).
  22. Franklyn JA, Betteridge J, et al. Long-term thyroxine treatment and bone mineral density. Lancet 1992;340:9-13.
  23. Gutekunst R, Smolarek H, Hasenpusch U, et al. Goiter epidemiology. Thyroid volume, iodine excretion, thyroglobulin and thyrotropin in Germany and Sweden. Acta Endocrinol (Copenh) 1986;112:494-501.
  24. Hennemann G, Krenning EP, Sankaranarayanan K. Place of radioactive iodine in treatment of thyrotoxicosis. Lancet 1986;1:1369-72.
  25. Hintze G, Windeler J, Baumert J, et al. Thyroid volume and goiter prevalence in the elderly as determined by ultrasound and their relationships to laboratory indices. Acta Endocrinol 1991;124:12-18.
  26. Hurley JR. Thyroid disease in the elderly. Med Clin North Am 1983;67:497-516.
  27. Isley WL. Thyroid dysfunction in the severely ill and elderly. Postgrad Med 1993;93:111-28.
  28. Jeffreys PM, Farran HEA, Hoffenberg R, et al. Thyroid function tests in the elderly. Lancet 1972;1:924-27.
  29. Jordan RM. Myxedema coma: the prognosis is improving. Endocrinologist 1993;3:149-53.
  30. Kabadi UM. Thyroid disorders and the elderly. Compr Ther 1989;15:53-65.
  31. Kunitake JM, Pekary AE, Hershman JM. Aging and the hypothalamic-pituitary-thyroid axis. In: Morley JE, Korenman SG (eds) Endocrinology and Metabolism in the Elderly. BlackwellScientific Publications, Boston 1992;92-110.
  32. Ladenson PW. Recognition and management of cardiovascular disease related to thyroid dysfunction. Am J Med 1990;88:638-41.
  33. Ladenson PW. Editorial: thyrotoxicosis and the heart: something old and something new. J Clin Endocrinol Metab 1993;77:332-33.
  34. Reed LP, Sidney IH. The Thyroid Gland In: Williams Textbook of Endocrinology, 8th edition, p. 357-489.
  35. Speroff L, Glass RH, Kase NG. Reproduction and the thyroid. In: Clinical Gynecologic Endocrinology and infertility 1994:667-87.
  36. Leung PM, Quinn ND, Belchetz PE. Amiodarone-induced thyrotoxicosis: not a benign condition. Int J Clin Pract 2002;56(1):44-46
  37. Levine HD. Compromise therapy in patients with angina pectoris and hypothyroidism: a clinical assessment. Am J Med 1980;69:411-18.
  38. Levy EG. Thyroid disease in the elderly. Med Clin North Am 1991;75:151-67.
  39. Lloyd WA, Goldberg IJL. Incidence of hypothyroidism in the elderly. Br Med J 1991;2:1256-59.
  40. Мandell SJ, Brent JA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med 1993;119:492-502.
  41. Marcocci C, Gianchecchi D, Masini I, et al. A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. J Endocrinol Invest 1991;13:513-20.
  42. Mariotti S, Franceschi C, Cossarizza A, et al. The aging thyroid. Endocr Rev 1995;16(6):686-715.
  43. Mazzaferri EL. Thyroid carcinoma: papillary and follicular. In Mazzaferri EL, Samaan N. Eds. Endocrine Tumors Cambridge: Blackwell Scientific Publications Inc. 1993:278-333.
  44. Melnichenko GA, Berketova TY. The advisability of screening for thyroid disease in peri- and postmenopausal women prior to HRT. In: The Thyroid and Age. European Thyroid Symposium Italy 1998:369.
  45. Mohacsi A, Worum F, Lorincz I, et al. Incidence of rhythm disorders in hyperthyreosis with special respect of old age forms. Acta Medica Hungarica 1990;47:21-29.
  46. Mokshagundam S, Barzel US. Thyroid disease in the elderly. J Am Geriatr Soc 1993;41:1361-69.
  47. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 1990;19:35-63.
  48. Nicoloff JT, Spencer CA. Clinical review 12: the use misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab 1990;71:553-58.
  49. Nordyke RA, Gilbert FI, Harada ASM. Graves' disease: influence of age on clinical findings. Arch Intern Med 1998;148:676-81.
  50. Parle JV, Franklyn JA, Cross KW, et al. Prevalence and follow-up of abnormal thyrotropin concentrations in the elderly in the United Kindom. Clin Endocrinol 1991;34:77-83.
  51. Potesta P, Murolo R, Costantini S, et al. High prevalence of asymptomatic hypothyroidism and hyperthyroidism in hospitalized elderly females. Eur Rev Med Pharmacol Sci 1996;18:129-33.
  52. Robuschi G, Safran M, Braverman LE, et al. Hypothyroidism in the elderly. Endocr Rev 1987;8:142-53.
  53. Ronnov-Jensen V, Kirkegaard C. Hyperthyroidism - a disease of old age? Br Med J 1973;1:41-43.
  54. Rosen CJ, Adler RA. Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. J Clin Endocr Metab 1992;75:1531.
  55. Ross DS, Neer RM, Ridgway EC, et al. Subclinical hypothyroidism and reduced bone density as a possible result of prolonged supression of the pituitary-thyroid axis with L-thyroxine. AM J Med 1987;82:1167-70.
  56. Roti E, Minelli R, Gardini E, et al. Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1992;75:1273-77.
  57. Roti E, Minelli R, Gardini E, et al. The use and misuse of thyroid hormone. Endocr Rev 1993;14:401-23.
  58. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. New Engl Jmed 1994;331:1249-52.
  59. Sawin CT, Chopra D, Azizi F, et al. The aging thyroid: increased prevalence of elevated serum thyrotropin in the elderly. JAMA 1979;242:247-50.
  60. Sawin CT, Castelli WP, Hershman JM, et al. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 19985;145:1386-88.
  61. Smith CL, Granger CV. Hypothyroidism producing reversible dementia. A challenge for medical rehabilitation. Am J Phys Med Rehabil 1992;71:28-30.
  62. Solomon B, Glinoer D, Lagasse R, et al. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 1990;70:1518-24.
  63. Solomon BL, Wartofsky L, Burman KD. Prevalence of fractures in postmenopausal women with thyroid disease. Thyroid 1993;3:17.
  64. Stall GM, Harris S, Sokol LJ, et al. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med 1991;91:5-14.
  65. Symth PPA, Bonar BD, Mc Colgan B, et al. Hypothyroidism and aging: is screening indicated? In: The Thyroid and Age. European Thyroid Symposium Italy 1998:373-74.
  66. Tunbridge WMG, Evered DC, et al. The spectrum of thyroid diseases in a community: the Wickham survey. Clin Endocrinol 1977;7:481-93.
  67. Vigna GV, Pansini F, Carantoni M, et al. Menopausal status, dyslipidemia and thyroid function: a cross-sectional study. Eur Menopause J 1997;4(3):95-102.
  68. Wartofsky L. Myxedema coma. In: Braverman LE, Utiger RD, etc. Werner and Ingbar's The Thyroid, ed 6. Lippincott, Philadelphia, 1991:1084-91.
  69. Wartofsky L. Osteoporosis: a growing concern for the thyroidologist. Thyroid Today 1988;11:1-11.
  70. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocr Rev 1982;3:164-217.
  71. Woeber KA. Iodine and thyroid disease. Med Clin North Am 1991;75:169-78.
  72. Wood LC, Ingbar SH. Hypothyroidism as a late sequela in patients with Graves' disease treated with antithyroid agents. J Clin Invest 1979;64:1429-36.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies